Patent · US Active

Triptan microporation delivery system

US11638809B2 · kind B2 · utility

1Cited by
17References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2020
Grant dateMay 2, 2023
Priority date
Expiry dateApr 28, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/327
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A transdermal delivery system for delivery of a triptan into a tissue membrane of a subject. The system includes a transdermal microporation apparatus for heating a skin surface and a triptan drug delivery patch. The drug delivery patch comprises a top layer comprising an adhesive, a middle layer comprising the triptan, and a bottom layer. A method for treating a subject comprises identifying a subject having a migraine, using the transdermal microporation apparatus to open a plurality of micropores in the skin of the subject, and applying the triptan drug delivery patch to the subject's skin over the micropores for a period of time effective to deliver the triptan through the micropores in an amount effective to treat the subject's migraine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.